Navigating challenges in drug‐coated balloon technology: The saga between paclitaxel and sirolimus continues

Catheterization and Cardiovascular InterventionsEarly View LETTER TO THE EDITOR Navigating challenges in drug-coated balloon technology: The saga between paclitaxel and sirolimus continues Bernardo Cortese MD, Corresponding Author Bernardo Cortese MD [email protected] orcid.org/0000-0002-5808-7810 Fondazione Ricerca e Innovazione Cardiovascolare, Milano, Italy DCB Academy, Milano, Italy Correspondence Bernardo Cortese, MD, FESC, FSCAI, Fondazione Ricerca e Innovazione Cardiovascolare, via E. Ponti, 49 Milan, DCB Academy, Milan, Italy. Email: [email protected]Search for more papers by this authorGabriel Rodrigues Pereira Tensol MD, Gabriel Rodrigues Pereira Tensol MD University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA Case Western Reserve University School of Medicine, Cleveland, Ohio, USASearch for more papers by this authorLuis Augusto Palma Dallan MD, Luis Augusto Palma Dallan MD University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA Case Western Reserve University School of Medicine, Cleveland, Ohio, USASearch for more papers by this authorPedro Rafael Vieira de Oliveira Salerno MD, Pedro Rafael Vieira de Oliveira Salerno MD University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA Case Western Reserve University School of Medicine, Cleveland, Ohio, USASearch for more papers by this authorAloke Finn MD, Aloke Finn MD orcid.org/0000-0003-0359-0184 CVPath Institute, Gaithersburg, Maryland, USA University of Maryland School of Medicine, Baltimore, Maryland, USASearch for more papers by this author Bernardo Cortese MD, Corresponding Author Bernardo Cortese MD [email protected] orcid.org/0000-0002-5808-7810 Fondazione Ricerca e Innovazione Cardiovascolare, Milano, Italy DCB Academy, Milano, Italy Correspondence Bernardo Cortese, MD, FESC, FSCAI, Fondazione Ricerca e Innovazione Cardiovascolare, via E. Ponti, 49 Milan, DCB Academy, Milan, Italy. Email: [email protected]Search for more papers by this authorGabriel Rodrigues Pereira Tensol MD, Gabriel Rodrigues Pereira Tensol MD University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA Case Western Reserve University School of Medicine, Cleveland, Ohio, USASearch for more papers by this authorLuis Augusto Palma Dallan MD, Luis Augusto Palma Dallan MD University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA Case Western Reserve University School of Medicine, Cleveland, Ohio, USASearch for more papers by this authorPedro Rafael Vieira de Oliveira Salerno MD, Pedro Rafael Vieira de Oliveira Salerno MD University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA Case Western Reserve University School of Medicine, Cleveland, Ohio, USASearch for more papers by this authorAloke Finn MD, Aloke Finn MD orcid.org/0000-0003-0359-0184 CVPath Institute, Gaithersburg, Maryland, USA University of Maryland School of Medicine, Baltimore, Maryland, USASearch for more papers by this author First published: 30 July 2024 https://doi.org/10.1002/ccd.31164Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. REFERENCES 1Ninomiya K, Serruys PW, Colombo A, et al. A prospective randomized trial comparing sirolimus-coated balloon with paclitaxel-coated balloon in de novo small vessels. JACC Cardiovasc Interv. 2023; 16(23): 2884-2896. doi:10.1016/j.jcin.2023.09.026 10.1016/j.jcin.2023.09.026 PubMedGoogle Scholar 2Serruys PW, Ninomiya K, Onuma Y. Reply. JACC Cardiovas Interv. 2024; 17(2): 318-319. doi:10.1016/j.jcin.2023.12.022 10.1016/j.jcin.2023.12.022 PubMedGoogle Scholar 3Cortese B, Pellegrini D, Latini RA, Di Palma G, Perotto A, Orrego PS. Angiographic performance of a novel sirolimus-coated balloon in native coronary lesions: the FAtebenefratelli SIrolimus COated NATIVES prospective registry. J Cardiovasc Med. 2019; 20(7): 471-476. doi:10.2459/JCM.0000000000000806 10.2459/JCM.0000000000000806 CASGoogle Scholar 4Cortese B, Kalkat H, Bathia G, Basavarajaiah S. The evolution and revolution of drug coated balloons in coronary angioplasty: an up-to-date review of literature data. Catheter Cardiovasc Interv. 2023; 102(6): 1069-1077. doi:10.1002/ccd.30891 10.1002/ccd.30891 PubMedGoogle Scholar 5Greco A, Sciahbasi A, Abizaid A, et al. Sirolimus-coated balloon versus everolimus-eluting stent in de novo coronary artery disease: rationale and design of the TRANSFORM II randomized clinical trial. Catheter Cardiovasc Interv. 2022; 100(4): 544-552. doi:10.1002/ccd.30358 10.1002/ccd.30358 PubMedWeb of Science®Google Scholar 6Cortese B, Testa L, Heang TM, et al. Sirolimus-coated balloon in an all-comer population of coronary artery disease patients. JACC Cardiovasc Interv. 2023; 16(14): 1794-1803. doi:10.1016/j.jcin.2023.05.005 10.1016/j.jcin.2023.05.005 PubMedWeb of Science®Google Scholar Early ViewOnline Version of Record before inclusion in an issue SCAI Member Sign in ReferencesRelatedInformation